Mid-Market Biopharma

Maximize your potential

Drive more predictable outcomes with the right development partner


Preferred provider

for Phase I/II/III research among mid-size biopharma customers and Phase IV industry leader (ISR 2014 report)

Optimize your timelines and investment

Imagine if your clinical development partner could help you achieve:

  • your target start up cycle times
  • up to 87% on-time patient enrollment
  • real-time access to project data
  • maximized product value

Quintiles can help you design smarter trials, execute more effectively and enhance your likelihood of achieving better outcomes.

A tailored approach for your specific needs and objectives

With more focused pipelines and greater budgetary demands, you face unique challenges. That’s why it’s important to work with a partner who understands your priorities and can help drive on-time, on-budget, high quality delivery. Our Quintiles therapeutic and operational experts will collaborate closely with your teams to provide fully integrated, tailored solutions that can help lead to more predictable outcomes for your products.

Informed insights yield optimized results

Since 2010, we have conducted more than 900 Phase I through IV clinical trials and more than 40 observational studies in 50 countries for mid-sized* biopharma companies. And in 2014, Quintiles helped develop or commercialize 100% of the Top 30 best-selling products of 2014 for mid-market biopharma companies*.

Want to learn more?

Please contact us today by clicking here.

Reference: *Mid-Market companies with annual R&D spend between US $200MM and $2B

The Power of Possibilities

Our goal is to help you realize the full potential of your products and your organization. As you grow, we stand beside you to explore the opportunities together.

Related Services

Phase II/III Clinical Trials
Market Access
Accelerate Adoption & Adherence